TY - JOUR
T1 - Bacterial pathogenesis and interleukin-17: Interconnecting mechanisms of immune regulation, host genetics, and microbial virulence that influence severity of infection
AU - Chamoun, Michelle N.
AU - Blumenthal, Antje
AU - Sullivan, Matthew J.
AU - Schembri, Mark A.
AU - Ulett, Glen C.
N1 - Funding Information:
This work was supported by the National Medical Research Council (NHMRC; Australia) under grant number APP1084889.
Publisher Copyright:
© 2018, © 2018 Informa UK Limited, trading as Taylor & Francis Group.
PY - 2018/7/4
Y1 - 2018/7/4
N2 - Interleukin-17 (IL-17) is a pro-inflammatory cytokine involved in the control of many different disorders, including autoimmune, oncogenic, and diverse infectious diseases. In the context of infectious diseases, IL-17 protects the host against various classes of microorganisms but, intriguingly, can also exacerbate the severity of some infections. The regulation of IL-17 expression stems, in part, from the activity of Interleukin-23 (IL-23), which drives the maturation of different classes of IL-17-producing cells that can alter the course of infection. In this review, we analyze IL-17/IL-23 signalling in bacterial infection, and examine the interconnecting mechanisms that link immune regulation, host genetics, and microbial virulence in the context of bacterial pathogenesis. We consider the roles of IL-17 in both acute and chronic bacterial infections, with a focus on mouse models of human bacterial disease that involve infection of mucosal surfaces in the lungs, urogenital, and gastrointestinal tracts. Polymorphisms in IL-17-encoding genes in humans, which have been associated with heightened host susceptibility to some bacterial pathogens, are discussed. Finally, we examine the implications of IL-17 biology in infectious diseases for the development of novel therapeutic strategies targeted at preventing bacterial infection.
AB - Interleukin-17 (IL-17) is a pro-inflammatory cytokine involved in the control of many different disorders, including autoimmune, oncogenic, and diverse infectious diseases. In the context of infectious diseases, IL-17 protects the host against various classes of microorganisms but, intriguingly, can also exacerbate the severity of some infections. The regulation of IL-17 expression stems, in part, from the activity of Interleukin-23 (IL-23), which drives the maturation of different classes of IL-17-producing cells that can alter the course of infection. In this review, we analyze IL-17/IL-23 signalling in bacterial infection, and examine the interconnecting mechanisms that link immune regulation, host genetics, and microbial virulence in the context of bacterial pathogenesis. We consider the roles of IL-17 in both acute and chronic bacterial infections, with a focus on mouse models of human bacterial disease that involve infection of mucosal surfaces in the lungs, urogenital, and gastrointestinal tracts. Polymorphisms in IL-17-encoding genes in humans, which have been associated with heightened host susceptibility to some bacterial pathogens, are discussed. Finally, we examine the implications of IL-17 biology in infectious diseases for the development of novel therapeutic strategies targeted at preventing bacterial infection.
KW - Bacterial pathogenesis
KW - host–pathogen interactions
KW - infection
KW - innate immunity
KW - interleukin-17
UR - http://www.scopus.com/inward/record.url?scp=85048736359&partnerID=8YFLogxK
U2 - 10.1080/1040841X.2018.1426556
DO - 10.1080/1040841X.2018.1426556
M3 - Review article
C2 - 29345518
AN - SCOPUS:85048736359
VL - 44
SP - 465
EP - 486
JO - Critical Reviews in Microbiology
JF - Critical Reviews in Microbiology
SN - 1040-841X
IS - 4
ER -